|Videos|May 25, 2023
Interview with Rentschler Biopharma's Federico Pollano
Author(s)Rentschler Biopharma
KEY LEARNING OBJECTIVES
- Viewers will gain a clear understanding of Rentschler Biopharma’s US offering currently and in the near future
- Viewers will understand what sets Rentschler Biopharma apart from other CDMOs in the field
- Viewers will gain a good feel for what it is like to be a client of Rentschler Biopharma
Related Content
Trending on Pharmaceutical Technology
1
Everything to Know about BMS & NVidia’s AI Supercomputer
2
Novo Nordisk Sues Eli Lilly Over Zepbound and Mounjaro Ads, Alleging Omitted GLP-1 Dosing Data
3
Brent Wilhelm on Cold Chain Pharmaceuticals Reshaping Shipping Needs
4
Can AI Fix Pharma's Last-Mile Delivery Blind Spot?
5